These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Two routes for producing human insulin utilizing recombinant DNA technology. Frank BH; Chance RE MMW Munch Med Wochenschr; 1983 May; Suppl 1():S14-20. PubMed ID: 6408426 [No Abstract] [Full Text] [Related]
5. Expression of active polypeptides in E. coli. Gilbert W Recomb DNA Tech Bull; 1981 Apr; 4(1):4-5. PubMed ID: 7019984 [No Abstract] [Full Text] [Related]
7. [Experimental studies on somatic gene therapy for diabetes. I. Structuring of recombinant from human insulin gene and ammalian expression vector PRC/CMV]. Xiao X; Wang H; Fang F; Sun Q Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Apr; 19(2):145-9. PubMed ID: 10453511 [TBL] [Abstract][Full Text] [Related]
8. [Preparation of recombinant human insulin--study of downstream process]. Yu R; Li X; Yang J; Wu W Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Oct; 21(5):805-8. PubMed ID: 15553863 [TBL] [Abstract][Full Text] [Related]
10. Preliminary studies on the immunogenicity and amount of Escherichia coli polypeptides in biosynthetic human insulin produced by recombinant DNA technology. Baker RS; Schmidtke JR; Ross JW; Smith WC Lancet; 1981 Nov; 2(8256):1139-42. PubMed ID: 6118580 [No Abstract] [Full Text] [Related]
11. From the NIH: Insulin and human growth hormone: triumphs in genetic engineering. JAMA; 1981 May; 245(17):1724-5. PubMed ID: 7012389 [No Abstract] [Full Text] [Related]
12. Overexpression for commercial production of recombinant human insulin as A-chain and B-chain fusion protein in Escherichia coli through genetically engineered plasmids. Chakraborty C Indian J Pathol Microbiol; 2004 Oct; 47(4):569-73. PubMed ID: 16295400 [TBL] [Abstract][Full Text] [Related]
13. [Bacterial synthesis of human insulin -- achievement of genetic engineering]. Germaniuk IaL Vrach Delo; 1981 Nov; (11):38-40. PubMed ID: 7043895 [No Abstract] [Full Text] [Related]
15. [Biological safety investigations of the production of human insulin by genetically-engineered E. coli K-12 cells. 3. Plasmid transfer by natural transformation and transduction]. Mieschendahl M; Schaffrath S; Lenkeit C; Danneberg G Zentralbl Hyg Umweltmed; 1993 May; 194(3):262-70. PubMed ID: 8338615 [TBL] [Abstract][Full Text] [Related]
16. [Biosynthesis and isolation of a recombinant protein for producing genetically-engineered human proinsulin]. Ivankin AN; Mitaleva SI; Nekliudov AD Prikl Biokhim Mikrobiol; 1998; 34(3):293-9. PubMed ID: 9644711 [TBL] [Abstract][Full Text] [Related]
17. The development of recombinant human insulin. Frank BH Dev Biol Stand; 1998; 96():91-5. PubMed ID: 9890521 [No Abstract] [Full Text] [Related]
18. Glutathione and its derivatives: produced by recombinant Escherichia coli and Saccharomyces cerevisiae. Murata K Bioprocess Technol; 1994; 19():159-83. PubMed ID: 7764757 [No Abstract] [Full Text] [Related]
20. Enhanced production of human mini-proinsulin in fed-batch cultures at high cell density of Escherichia coli BL21(DE3)[pET-3aT2M2]. Shin CS; Hong MS; Bae CS; Lee J Biotechnol Prog; 1997; 13(3):249-57. PubMed ID: 9190075 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]